CCXI Short Information, ChemoCentryx Inc.
home / stock / ccxi / ccxi short
| Twenty Trading Day Totals | |
|---|---|
| Total Shorted Volume | 4,716,087 |
| Total Actual Volume | 37,928,797 |
| Short Trends | |
|---|---|
| Cover Days | 6 |
| Short Days | 6 |
| No Change Days | 8 |
| Averages | |
|---|---|
| Average Short Volume | 235,804 |
| Average Short Percentage | 43.74% |
Is there a CCXI Short Squeeze or Breakout about to happen?
See the CCXI Short Analysis for free Sign up or Login
Powered by Squeeze Report
CCXI Twenty Trading Day's Volume to Short Volume Chart
CCXI Twenty Trading Day Price Chart
CCXI Short Data Results Days
| Stock Date | Open Price | Close Price | High | Low | Total Volume | Short Volume | Short Percentage |
|---|---|---|---|---|---|---|---|
| 2022-05-23 | 22.79 | 22.36 | 22.91 | 21.96 | 989,248 | 88,264 | 39.0071 |
| 2022-05-19 | 20.79 | 22.05 | 22.9 | 20.79 | 2,211,383 | 538,483 | 64.3791 |
| 2022-05-18 | 20 | 20.86 | 21.44 | 19.83 | 1,499,045 | 212,471 | 43.2688 |
| 2022-05-17 | 19.66 | 20.91 | 21.01 | 19.44 | 1,329,401 | 113,692 | 41.5016 |
| 2022-05-16 | 19.14 | 19.2 | 20.37 | 18.75 | 1,178,724 | 148,435 | 49.0501 |
| 2022-05-12 | 16.21 | 17.35 | 17.63 | 16.16 | 1,341,551 | 143,447 | 45.1122 |
| 2022-05-11 | 17.83 | 16.49 | 18.69 | 16.49 | 2,184,092 | 286,453 | 52.9110 |
| 2022-05-10 | 16.16 | 17.89 | 18.12 | 15.31 | 3,285,909 | 283,818 | 26.5620 |
| 2022-05-09 | 16.81 | 15.36 | 17.03 | 14.95 | 2,669,740 | 421,731 | 48.3914 |
| 2022-05-06 | 18.26 | 17.38 | 19.48 | 17.19 | 8,371,381 | 822,439 | 23.5439 |
| 2022-05-04 | 17.82 | 16.99 | 17.82 | 16.16 | 2,563,547 | 577,300 | 65.5888 |
| 2022-05-03 | 18.7 | 17.68 | 18.96 | 17.51 | 1,436,145 | 97,321 | 33.5376 |
| 2022-05-02 | 18.55 | 18.77 | 19.05 | 17.76 | 1,680,464 | 110,793 | 26.2069 |
| 2022-04-29 | 18.9 | 18.46 | 19.4 | 18.36 | 1,141,214 | 59,380 | 22.1526 |
| 2022-04-28 | 19.41 | 19.04 | 19.41 | 17.9 | 895,914 | 71,957 | 27.4791 |
| 2022-04-27 | 19.25 | 19.07 | 19.76 | 18.82 | 809,970 | 79,321 | 39.0459 |
| 2022-04-26 | 19.7 | 19.19 | 19.76 | 19.12 | 1,434,329 | 174,498 | 55.2930 |
| 2022-04-25 | 19.1 | 19.84 | 20.03 | 19.01 | 816,690 | 115,471 | 58.7307 |
| 2022-04-21 | 21.11 | 19.69 | 21.4 | 19.53 | 1,048,831 | 140,803 | 47.4412 |
| 2022-04-20 | 21.21 | 20.88 | 21.71 | 20.75 | 1,041,219 | 230,010 | 65.6200 |
News, Short Squeeze, Breakout and More Instantly...
-
-- Supports plans to advance TAVNEOS ® (avacopan) into Phase III development for the treatment of patients with most severe form of hidradenitis suppurativa, Hurley Stage III -- SAN CARLOS, Calif., May 18, 2022 (GLOBE NEWSWIRE) -- ChemoCentryx, Inc., (Nasdaq: CCXI),...
-
SAN CARLOS, Calif., May 16, 2022 (GLOBE NEWSWIRE) -- ChemoCentryx, Inc., (Nasdaq: CCXI), today announced that Thomas J. Schall, Ph.D., President and Chief Executive Officer, will present at the H.C. Wainwright Global Investment Conference on Tuesday, May 24, 2022 at 12:30 p.m. ET. The confe...
-
SAN CARLOS, Calif., May 11, 2022 (GLOBE NEWSWIRE) -- ChemoCentryx, Inc., (Nasdaq: CCXI), today announced upcoming presentations at three key medical conferences that will highlight findings from the pivotal Phase III ADVOCATE trial that supported the approval of TAVNEOS ® (avacopan...